Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujiao Zhang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Discover Oncology|March 13, 2025
USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCCShujiao Zhang, Feihu Ding, Fuxin Jia, et al.
Molecules (Basel, Switzerland)|February 26, 2025
Co-Improvement in Electrocatalytic Hydrogen Evolution Performance of MoS<sub>2</sub> by Ni Doping and Graphene Oxide CompoundingGuiquan Guo, Yuqin Li, Shujiao Zhang, et al.
Frontiers in Pharmacology|August 28, 2024
Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammationShujiao Zhang, Shuaixing Zhang, Xuehui Bai, et al.
Optics Letters|October 14, 2022
Mid-infrared polarization-insensitive grating couplerHaoran Gao, Rongxiang Guo, Shujiao Zhang, et al.
Clinical and Translational Science|May 8, 2023
CB-HRNet: A Class-Balanced High-Resolution Network for the evaluation of endoscopic activity in patients with ulcerative colitisGe Wang, Shujiao Zhang, Jie Li, et al.
European Journal of Pharmacology|November 9, 2025
Targeting FoxO1-STX17-mediated autophagic flux: Quercetin's therapeutic mechanism in diabetic nephropathyBaoluo Hou, Yachun Li, Jingyi Tang, et al.
BMC Musculoskeletal Disorders|January 17, 2025
Clinical and novel insights into risk factors for sarcopenia in dialysis patients: a systematic review and meta-analysisYifei Zhang, Zeyu Zhang, Zijing Cao, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 28, 2025
Mechanisms of Xuefu Zhuyu decoction in treating diabetic kidney disease-induced renal fibrosis: UPLC-Q/TOF-MS, network pharmacology, and experimental validationYifei Zhang, Shuaixing Zhang, Zeyu Zhang, et al.
European Journal of Pharmacology|June 9, 2024
Acteoside delays the fibrosis process of diabetic nephropathy by anti-oxidation and regulating the autophagy-lysosome pathwayMengqi Zhou, Shujiao Zhang, Xuehui Bai, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Discover Oncology|March 13, 2025
USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCCShujiao Zhang, Feihu Ding, Fuxin Jia, et al.
Molecules (Basel, Switzerland)|February 26, 2025
Co-Improvement in Electrocatalytic Hydrogen Evolution Performance of MoS<sub>2</sub> by Ni Doping and Graphene Oxide CompoundingGuiquan Guo, Yuqin Li, Shujiao Zhang, et al.
Frontiers in Pharmacology|August 28, 2024
Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammationShujiao Zhang, Shuaixing Zhang, Xuehui Bai, et al.
Optics Letters|October 14, 2022
Mid-infrared polarization-insensitive grating couplerHaoran Gao, Rongxiang Guo, Shujiao Zhang, et al.
Clinical and Translational Science|May 8, 2023
CB-HRNet: A Class-Balanced High-Resolution Network for the evaluation of endoscopic activity in patients with ulcerative colitisGe Wang, Shujiao Zhang, Jie Li, et al.
European Journal of Pharmacology|November 9, 2025
Targeting FoxO1-STX17-mediated autophagic flux: Quercetin's therapeutic mechanism in diabetic nephropathyBaoluo Hou, Yachun Li, Jingyi Tang, et al.
BMC Musculoskeletal Disorders|January 17, 2025
Clinical and novel insights into risk factors for sarcopenia in dialysis patients: a systematic review and meta-analysisYifei Zhang, Zeyu Zhang, Zijing Cao, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 28, 2025
Mechanisms of Xuefu Zhuyu decoction in treating diabetic kidney disease-induced renal fibrosis: UPLC-Q/TOF-MS, network pharmacology, and experimental validationYifei Zhang, Shuaixing Zhang, Zeyu Zhang, et al.
European Journal of Pharmacology|June 9, 2024
Acteoside delays the fibrosis process of diabetic nephropathy by anti-oxidation and regulating the autophagy-lysosome pathwayMengqi Zhou, Shujiao Zhang, Xuehui Bai, et al.
Pageof 1